Literature DB >> 12452747

Quetiapine therapy for posttraumatic stress disorder.

S Pirzada Sattar1, Bernadette Ucci, Kathleen Grant, Subhash C Bhatia, Frederick Petty.   

Abstract

OBJECTIVE: To report a case of improvement in posttraumatic stress disorder (PTSD) after adjunctive therapy with quetiapine. CASE
SUMMARY: A 49-year-old white man witnessed a traumatic event and experienced severe PTSD. He was started on paroxetine, with increases in dosage and no significant improvement. Quetiapine was added to his regimen, with increased doses resulting in improvement of PTSD symptoms, both clinically and as measured on the Hamilton-D rating scale for depression and the clinician-administered PTSD screen. DISCUSSION: This is the first case published in the English language literature describing improvement in PTSD symptoms after treatment with quetiapine. There are several treatment options for PTSD, but some severe cases may require treatment with antipsychotic medications. Because of the lower risks of serious adverse effects, the newer atypical antipsychotics are much safer than the older antipsychotics. Although use of risperidone and olanzapine in the successful treatment of PTSD has been reported in the literature, there are no reports of quetiapine use in this clinical condition.
CONCLUSIONS: Quetiapine appeared to improve clinical signs and symptoms of PTSD in this patient. It may be a treatment option in other severe cases of PTSD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452747     DOI: 10.1345/aph.1C040

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  9 in total

1.  Pharmacotherapy of treatment-resistant combat-related posttraumatic stress disorder with psychotic features.

Authors:  Nela Pivac; Dragica Kozarić-Kovacić
Journal:  Croat Med J       Date:  2006-06       Impact factor: 1.351

2.  Use of antipsychotics in the treatment of post-traumatic stress disorder.

Authors:  Babatunde Adetunji; Maju Mathews; Adedapo Williams; Kumar Budur; Manu Mathews; Jamal Mahmud; Thomas Osinowo
Journal:  Psychiatry (Edgmont)       Date:  2005-04

Review 3.  Post-traumatic stress disorder in women: epidemiological and treatment issues.

Authors:  Soraya Seedat; Dan J Stein; Paul D Carey
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  Potential benefits of quetiapine in the treatment of substance dependence disorders.

Authors:  S Pirzada Sattar; Subhash C Bhatia; Frederick Petty
Journal:  J Psychiatry Neurosci       Date:  2004-11       Impact factor: 6.186

5.  Psychopharmacology for medically ill adolescents.

Authors:  Brenda Bursch; Marcy Forgey
Journal:  Curr Psychiatry Rep       Date:  2013-10       Impact factor: 5.285

6.  Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder.

Authors:  Nela Pivac; Dragica Kozaric-Kovacic; Dorotea Muck-Seler
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

Review 7.  Assessment and management of pediatric iatrogenic medical trauma.

Authors:  Marcy Forgey; Brenda Bursch
Journal:  Curr Psychiatry Rep       Date:  2013-02       Impact factor: 5.285

8.  Functional neuroimaging of reward circuitry responsivity to monetary gains and losses in posttraumatic stress disorder.

Authors:  Igor Elman; Steven Lowen; Blaise B Frederick; Won Chi; Lino Becerra; Roger K Pitman
Journal:  Biol Psychiatry       Date:  2009-07-29       Impact factor: 12.810

9.  Quetiapine mitigates the ethanol-induced oxidative stress in brain tissue, but not in the liver, of the rat.

Authors:  Jin-Hong Han; Hong-Zhao Tian; Yang-Yang Lian; Yi Yu; Cheng-Biao Lu; Xin-Min Li; Rui-Ling Zhang; Haiyun Xu
Journal:  Neuropsychiatr Dis Treat       Date:  2015-06-15       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.